7 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Management of Fever ... stable and no medical ... #neutropenic #fever ... #IDSA #Algorithm
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Managing BPD Clinical ... UK national BPD clinical ... summarised in Tables ... #Medications #Pharmacotherapy ... Effectiveness #Table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
highlighted circle= clinical ... trial Ever Arias ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology #Table
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
with previously stable ... with electrolyte disorders ... 109 mm Hg) with clinical ... Neurologic disorders ... Differential #Diagnosis #indications
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... neutropenia < 7 days and clinically ... stable and no medical ... >7 days or • Clinically ... #IDSA #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... functional status - Able ... metabolic equivalent able ... Change in clinical ... Stable patients
Medications for the Treatment of Hyperkalemia
The goals of acute treatment are to prevent potentially life-threatening cardiac
the underlying disorder ... Figure 3 is an algorithm ... hyperkalemia, and Table ... 3 summarizes medications ... #Management #Medications